Free shipping on all orders over $ 500

 About 1 result found for searched term "1225278-16-9" (0.134 seconds)

Cat.No.  Name Target
M20635 DCC-2618 c-Kit
DCC-2618 is an orally bioavailable switch pocket control inhibitor of wild-type and mutated forms of KIT and PDGFR with potential antineoplastic activity. It also inhibits several other kinases, including VEGFR2, TIE2, PDGFR-beta and CSF1R, thereby further inhibiting tumor cell growth.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.